Financial Instruments: IFRS-9 — Impairment (Portfolio 5186)

Description

Bloomberg Tax and Accounting Portfolio 5186, Financial Instruments: IFRS 9—Impairment, examines how an entity accounts for impairment of nonderivative financial assets under International Financial Reporting Standards (IFRSs). The Portfolio focuses on the requirements of IFRS 9, Financial Instruments (July 2014).

This Portfolio does all of the following:
• Paraphrases the existing authoritative international guidance as set out in IFRS 9;
• Offers insight into the rationale for, and practical consequences of, the authoritative guidance;
• Provides context for and observations about illustrative examples set out in the authoritative guidance; and
• At a high-level, notes how authoritative generally accepted accounting principles in the United States (as set out in the FASB Accounting Standards Codification) compare and contrast with the authoritative international guidance.

The analysis is drawn from review of the authoritative guidance, but also from the supporting project materials of the International Accounting Standards Board (IASB)—for example, the basis for board’s conclusions and related dissents, exposure drafts, comment letters, and other project documentation.

This Portfolio may be cited as Bloomberg Tax and Accounting Portfolio 5186, Green, Financial Instruments: IFRS 9—Impairment (Accounting Policy and Practice Series). Within the Accounting Policy and Practice Portfolio Series, however, references to the Portfolios will include only the Portfolio numbers and titles.

Table of Contents

I. Introduction
II. Scope of the Guidance
III. Appropriate Information
IV. Monitoring Credit Risk
V. Estimating Expected Credit Losses
VI. Subsequent Accounting Other Than for Impairment
VII. Credit-Risk Disclosures
VIII. Adoption of the Expected Credit Losses Model

Visit our CECL Credit Losses Resource Hub